All lobbying filings

CROSSROADS STRATEGIES, LLC

Lobbying for INDIVIOR INC. · pharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2025

Apr 1 - June 30 · Posted Jul 20, 2025

Income

$50,000.00

What the client paid this registrant for the period.

Client based in

California

Official filing document

Government bodies contacted 4

Executive Office of the President (EOP)
Health & Human Services, Dept of (HHS)
HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 1968
Full-Year Continuing Appropriations and Extensions Act, 2025
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.

Lobbying activity 2

Pharmacy

Issues related to overdose reversal products including Naloxone; H.R.1968, Full-Year Continuing Appropriations and Extensions Act, 2025 (P.L.119-4); FY2026 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2026 Commerce, Justice, Science, and Related Agencies Appropriations.

Medicare/Medicaid

Medicaid policies related to substance use disorder; H.R.1, One Big Beautiful Bill Act.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.